Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Lars Harbaum
Metabolomic signature of right ventricular–pulmonary arterial coupling differentiates hemodynamic response to imatinib therapy in pulmonary arterial hypertension
Keywords Pulmonary arterial hypertension Right ventricle RV–PA coupling Metabolomics Imatinib Get full text access Log in, subscribe or purchase for full access. References 1. Hassoun, P.M. Pulmonary arterial hypertension N Engl J Med. 2021; 385:2361-2376 2. Hemnes, A.R. ∙ Celermajer, D.S. ∙ D'Alto, M. ... Pathophysiology of the right ventricle and its pulmonary vascular interaction Eur Respir J. 2024; 64 3. Houston, B.A. ∙ Brittain, E.L. ∙ Tedford, R.J. Right ventricular failure N Engl J Med.
Metabolomic Signature of RV-PA Coupling Differentiates Haemodynamic Response to Imatinib Therapy in Pulmonary Arterial Hypertension
Keywords pulmonary arterial hypertension Right ventricle RV-PA coupling Metabolomics Imatinib Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Hassoun, P.M. Pulmonary Arterial Hypertension The New England journal of medicine. 2021; 385:2361-2376 2. Hemnes, A.R. ∙ Celermajer, D.S. ∙ D'Alto, M. ... Pathophysiology of the right ventricle and its pulmonary vascular interaction The European respiratory journal. 2024; 64 3.
Sex-specific genetic determinants of right ventricular structure and function
The authors have declared no competing interest. The UK Biobank was established through core funding by the Wellcome Trust medical charity, the Medical Research Council, the Department of Health, the Scottish Government, and the Northwest Regional Development Agency. It has also had funding from the Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK.
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension
Mark Toshner, Colin Church, Lars Harbaum, Christopher Rhodes, Sofia S. Villar Moreschi, James Liley, Rowena Jones, Amit Arora, Ken Batai, Ankit A. Desai, John G. Coghlan, J. Simon R. Gibbs, Dee Gor, Stefan Gräf, Louise Harlow, Jules Hernandez-Sanchez, Luke S. Howard, Marc Humbert, Jason Karnes, David G. Kiely, Rick Kittles, Emily Knightbridge, Brian Lam, Katie A. Lutz, William C. Nichols, Michael W. Pauciulo, Joanna Pepke-Zaba, Jay Suntharalingam, Florent Soubrier, Richard C. Trembath, Tae-Hwi L.
Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH
Mark Toshner, Colin Church, Lars Harbaum, Christopher Rhodes, Sofia S. Villar Moreschi, James Liley, Rowena Jones, Amit Arora, Ken Batai, Ankit A. Desai, John G. Coghlan, J. Simon R. Gibbs, Dee Gor, Stefan Gräf, Louise Harlow, Jules Hernandez-Sanchez, Luke S. Howard, Marc Humbert, Jason Karnes, David G. Kiely, Rick Kittles, Emily Knightbridge, Brian Lam, Katie A. Lutz, William C. Nichols, Michael W. Pauciulo, Joanna Pepke-Zaba, Jay Suntharalingam, Florent Soubrier, Richard C. Trembath, Tae-Hwi L.
Blood carbon dioxide tension and risk in pulmonary arterial hypertension
Highlights • P aCO 2 was prognostic in patients with PAH at diagnosis and follow-up. • P aCO 2 was an independent non-invasive prognostic parameter. • Integration of P aCO 2 improved contemporary risk assessment strategies. • P aCO 2 related to hemodynamic but not pulmonary function parameters. Abstract Background Low partial pressure of blood carbon dioxide (P aCO 2) is common in patients with pulmonary arterial hypertension (PAH) and may inform on clinical outcomes.
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension Lars Harbaum1, Pavandeep Ghataorhe1, John Wharton1, Beatriz Jiménez2, Luke S G Howard3,4, J Simon R Gibbs3,4, Jeremy K Nicholson5, Christopher J Rhodes1, Martin R Wilkins1 1 Department of Medicine, Imperial College London, London, UK 2 Imperial Clinical Phenome Centre, Department of Surgery and Cancer, Imperial College London, London, UK 3 National Heart and Lung Institute,...
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension Lars Harbaum1, Pavandeep Ghataorhe1, John Wharton1, Beatriz Jiménez2, Luke S G Howard3,4, J Simon R Gibbs3,4, Jeremy K Nicholson5, Christopher J Rhodes1, Martin R Wilkins1 1Department of Medicine, Imperial College London, London, UK 2Imperial Clinical Phenome Centre, Department of Surgery and Cancer, Imperial College London, London, UK 3National Heart and Lung Institute, Imperial...
Bleeding complications after endoscopic lung volume reduction coil treatment: A retrospective observational study
Bleeding complications after endoscopic lung volume reduction coil treatment: A retrospective observational study Marcel Simon, Harald Ittrich, Lars Harbaum, Tim Oqueka, Stefan Kluge, Hans Klose European Respiratory Journal Sep 2016, 48 (suppl 60) PA1857; DOI: 10.1183/13993003.congress-2016.PA1857
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Lars
Contact Lars, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack